Pillstats
Rx only · Capsule · Oral

Temozolomide

Brands: Temodar · Temozolomide

11 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US66 NDCs
11 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC—
RxCUI (US)—
US makers11 labelers
Packages152
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 77 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$6.16$12.31$18.47$24.63Mar 2025Dec 2025Jun 2026
$9.656
Latest avg · Jun 17, 2026
-55%
Since Mar 19, 2025
11
Active US suppliers
34%
Top-2 supplier share*

Who makes it11 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown35SUPPLYING
Rising Pharma Holdings, Inc.unknown17SUPPLYING
Camber Pharmaceuticals, Inc.unknown12SUPPLYING
Merck Sharp & Dohme LLC.unknown11SUPPLYING
Accord Healthcare Inc.unknown11SUPPLYING
Amneal Pharmaceuticals LLCunknown11SUPPLYING
Ascend Laboratories, LLCunknown11SUPPLYING
Bryant Ranch Prepackrepackager11SUPPLYING
Devatis, Inc.unknown11SUPPLYING
Nivagen Pharmaceuticals, Inc.unknown11SUPPLYING
CivicaScript LLCunknown11SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.